𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Benign prostatic hyperplasia: A review of its histogenesis and natural history

✍ Scribed by Oesterling, Joseph E.


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
647 KB
Volume
29
Category
Article
ISSN
0270-4137

No coin nor oath required. For personal study only.

✦ Synopsis


Although the exact etiology of benign prostatic hyperplasia (BPH) is not well-defined, it is thought to occur as a result of epithelial-stromal interactions in the appropriate hormonal milieu. Benign prostatic hyperplasia originates in the periurethral and transition zones of the prostate in a microscopic (histologically identifiable) state as early as the third decade of life. With advancing age and the presence of androgens, approximately 50% of microscopic BPH will develop into macroscopic (palpably enlarged prostate) BPH. However, clinically significant BPH, necessitating treatment, will develop in only 50% of men with an enlarged prostate gland. In the United States, the estimated risk of a 50-yearold man undergoing therapeutic intervention in his lifetime is approximately 40%. If left untreated, a significant number of symptomatic patients will remain stable or improve without adverse sequelae.


πŸ“œ SIMILAR VOLUMES


Family history of cancer and the risk of
✍ Eva Negri; Claudio Pelucchi; Renato Talamini; Maurizio Montella; Silvano Gallus; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 76 KB πŸ‘ 2 views

## Abstract We analysed the relation between family history of cancer in first‐degree relatives and risk of prostate cancer (PC) and benign prostatic hyperplasia (BPH) using data from a multicentric case‐control study conducted in Italy from 1991 to 2002 on 1,294 cases of incident, histologically c

Benign prostatic hypertrophy and uraemia
✍ A. David Beck πŸ“‚ Article πŸ“… 1970 πŸ› John Wiley and Sons 🌐 English βš– 517 KB

## Abstract The overall hospital mortality-rate of 315 patients with benign obstructive prostatic disease and renal failure was 21 per cent. One hundred and ninety-four patients (61Β·6 per cent) were dealt with by prostatic surgery, in the majority of whom a significant improvement in renal function

31P NMR of phospholipid metabolites in p
✍ Richard A. Komoroski; John C. Holder; Alex A. Pappas; Alex E. Finkbeiner πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 62 KB

## Abstract ^1^H MRSI in vivo is increasingly being used to diagnose prostate cancer noninvasively by measurement of the resonance from choline‐containing phospholipid metabolites. Although ^31^P NMR in vivo or in vitro is potentially an excellent method for probing the phospholipid metabolites pro